Clinical Trial Update: Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )

View source ↗

Summary

Clinical trial GOAL-AF is evaluating outcomes in overweight patients with atrial fibrillation after ablation when treated with liraglutide; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Obesity

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Atrial Fibrillation, Recurrence | Status: ACTIVE_NOT_RECRUITING